Author

Danielle Gulick

University of South FloridaORCID 0000-0002-5052-780XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Assay:electronic health records· 1

Frequent Co-Authors

Alex Leake· 2 shared Alexander D. Maitland· 1 shared Alexandra Gekhtina· 1 shared Chris Langdale· 1 shared Christopher G. WitowskiiD· 1 shared Daniel Moreira‐SilvaiD· 1 shared Elena BrayiD· 1 shared Emilia M BuitragoiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Alex Leake

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Gamma CV as a Marker of Circadian Disruption in C57BL/6J Mice: Correlating Neural Desynchrony with Locomotor, Thermal, and Sleep Dysrhythmia across a Spectrum of Circadian Rhythms Disruption paradigms.

Génesis D’aloisio, Alexandra Gekhtina, Kyle Laney, Trever Brown, Daniel Moreira‐Silva, Alex Leake, Chris Langdale, Joshua J. Gamsby, Danielle Gulick

This study identifies Gamma CV as a sensitive marker of circadian disruption in mice by analyzing neural, thermal, and locomotor data across different circadian stress paradigms.

bioRxiv · May 5, 2026 · PreprintNeuroscience

Serotonergic Polypharmacology of 2-Halogenated Tryptamines

Jeanine Yacoub, Elena Bray, Jude Bayyat, Grant C. Glatfelter, Alex Leake, Emilia M Buitrago, Alexander D. Maitland, John S. Partilla, Natalie G. Cavalco, Serena S. Schalk, Josie C Lammers, Michael H. Baumann, John D. McCorvy, James W. Leahy, Danielle Gulick, , Jacqueline L. von Salm

This study designs and tests 2-halogenated tryptamines to reduce psychoactive and cardiotoxic effects while retaining therapeutic serotonergic activity.

bioRxiv · Apr 21, 2026 · PreprintPharmacology & Toxicology